These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18325022)

  • 21. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury.
    Fock J; Galea MP; Stillman BC; Rawicki B; Clark M
    Brain Inj; 2004 Jan; 18(1):57-63. PubMed ID: 14660236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidimensional evaluation of changes in limb function following botulinum toxin injection in persons with stroke.
    Amatya B; Cofré Lizama LE; Elmalik A; Bastani A; Galea MP; Khan F
    NeuroRehabilitation; 2019; 45(1):67-78. PubMed ID: 31403954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of botulinum neurotoxin on spatio-temporal gait parameters of patients with chronic stroke: a prospective open-label study.
    Gastaldi L; Lisco G; Pastorelli S; Dimanico U
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):609-18. PubMed ID: 25519765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol.
    Chu WH; Gupta AD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):23-9. PubMed ID: 27532646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective tibial neurotomy in the treatment of spastic equinovarus foot in hemiplegic patients: a 2-year longitudinal follow-up of 30 cases.
    Deltombe T; Gustin T
    Arch Phys Med Rehabil; 2010 Jul; 91(7):1025-30. PubMed ID: 20599040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
    Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
    J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tibial nerve neurotomy on posture and gait in stroke patients: A focus on patient-perceived benefits in daily life.
    Le Bocq C; Rousseaux M; Buisset N; Daveluy W; Blond S; Allart E
    J Neurol Sci; 2016 Jul; 366():158-163. PubMed ID: 27288797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Post-stroke spasticity of the lower limb: a comprehensive rehabilitation of patients with the use of botulinum toxin (onabotulinumtoxin A)].
    Kostenko EV; Petrova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):39-48. PubMed ID: 25591515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Krajnik J; Luecke D; Jahnke MT; Gregoric M; Mauritz KH
    Stroke; 1996 Mar; 27(3):455-60. PubMed ID: 8610313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unstable gait due to spasticity of the rectus femoris: gait analysis and motor nerve block.
    Gross R; Leboeuf F; Rémy-Néris O; Perrouin-Verbe B
    Ann Phys Rehabil Med; 2012 Dec; 55(9-10):609-22. PubMed ID: 23043733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke.
    Karadag-Saygi E; Cubukcu-Aydoseli K; Kablan N; Ofluoglu D
    Top Stroke Rehabil; 2010; 17(4):318-22. PubMed ID: 20826420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A; Vachalathiti R; Poungvarin N
    J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial.
    Kirazli Y; On AY; Kismali B; Aksit R
    Am J Phys Med Rehabil; 1998; 77(6):510-5. PubMed ID: 9862538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study to investigate the combined use of Botulinum toxin type-a and ankle foot orthosis for the treatment of spastic foot in chronic hemiplegic patients.
    Pradon D; Hutin E; Khadir S; Taiar R; Genet F; Roche N
    Clin Biomech (Bristol, Avon); 2011 Oct; 26(8):867-72. PubMed ID: 21592635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
    Albani G; Cimolin V; Galli M; Vimercati S; Bar D; Campanelli L; Gandolfi R; Lombardi R; Mauro A
    Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.